CAPTRUST FINANCIAL ADVISORS

Position in PEN — Penumbra Inc

CIK 1512024 RALEIGH, NC

Position in PEN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$290,490

-$331,771 QoQ

Shares Held

920

-51.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#312

of 446 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $192,998,899 across 51 Medical Devices names. PEN ranks #26 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	509,302	$46,214,063
2	STE	STERIS plc	209,519	$44,118,415
3	SYK	Stryker Corp	138,667	$43,657,918
4	MDT	Medtronic plc	258,603	$20,230,512
5	EW	Edwards Lifesciences Corp	60,926	$5,511,365
6	BSX	Boston Scientific Corp	123,736	$5,281,052
7	DXCM	Dexcom Inc	47,517	$3,200,269
8	GEHC	GE HealthCare Technologies Inc.	47,861	$3,063,582

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$290,490	920	-51.5%	Shares	Sole	2026-08-13
2026-03-31	$622,261	1,895	-45.2%	Shares	Sole	2026-05-15
2025-12-31	$1,075,748	3,460	+76.3%	Shares	Sole	2026-02-17
2025-09-30	$497,267	1,963	-1.2%	Shares	Sole	2025-11-19
2025-06-30	$509,667	1,986	+33.4%	Shares	Sole	2025-08-15
2025-03-31	$398,173	1,489	+3.0%	Shares	Sole	2025-05-15
2024-12-31	$343,158	1,445	+559.8%	Shares	Sole	2025-02-14
2022-06-30	$27,269	219	+44.1%	Shares	Sole	2022-08-23
2022-03-31	$33,763	152	+5.6%	Shares	Sole	2022-05-16
2021-12-31	$41,374	144	+53.2%	Shares	Sole	2022-02-14
2021-09-30	$25,051	94	-49.2%	Shares	Sole	2021-11-16
2021-06-30	$50,701	185	+125.6%	Shares	Sole	2021-08-16
2021-03-31	$22,187	82	+26.2%	Shares	Sole	2021-05-17
2020-12-31	$11,375	65	+8.3%	Shares	Sole	2021-02-16
2020-09-30	$11,662	60	—	Shares	Sole	2020-11-17
No filing history on record for this holder in this stock.